A specialized pen-based medication, Mounjaro Injections helps diabetic patients manage sugar levels. Commonly known by a brand name, it contains an active ingredient called tripeptide. Initially, the dosage is minimal, administered once a week, gradually increasing. It works by targeting the pancreas to increase insulin release and inhibit glucagon release. Insulin promotes cells to take up glucose from the bloodstream. Effective utilization yields increased energy and lower blood sugar levels.